Panacea Biotech-A high risk, huge reward stock!Panacea biotech is in news for developing Dengue vaccine.
Technically, stock has bounced from support trendline and is looking strong to test ATH levels once again which can be around 2x from CMP.
Keep in watchlist. A very risky volatile stock and is not a recommendation.
Vaccine
SNOWMAN BREAKOUTSNOWMAN BUY around 64-70 zone . Targets: 85/95/105++++
SL: Below 50
Points:-
1. SNOWMAN fundamentals are very strong as it preserves vaccines and is the largest importer of the vaccine .
2. Sentiments are also with the SNOWMAN.
3. Like the prices are going up after 2 years of consolidation .
4. It will break the 70 level and continue the really up to 96 around.
5. It also makes Pole and Flag Pattern with High Volumes .